Skip to main content

Residents have protected didactic time on Thursday afternoons, consisting of several consecutive learning session/conferences, including:

  • Morbidity and mortality conference. This conference alternates between obstetrics and gynecology, with dedicated faculty moderators who focus on medical decision-making in complicated cases presented by the senior resident on each service.
  • Weekly didactic teaching. This is a structured teaching session each week with topics mapping to the CREOG Learning Objectives such that all learning objectives are covered within a 2-year cycle, as shown below.
  • Grand Rounds
  • Additional sessions encompassing advocacy, residents as teachers, well-being, and research.



Didactic topics for 2022-2023 (“B” topics)



  • Gametogenesis/Embryology/Teratology
  • Contraception and abortion, non-contraceptive use of contraceptives (including PMS and PMDD) 
  • Establishing GA and basics of ultrasound, antenatal surveillance 
  • Diagnosis/management of PCOS, androgen excess 
  • Vaginal bleeding in pregnancy/abnormal placentation 
  • Normal vaginal microbiome, lower genital tract infections, STIs 
  • Emergency care/trauma in pregnancy
  • Urinary Tract Injury 
  • Operative vaginal delivery and vaginal delivery complications (obstetric lacerations, hematomas, retained placenta)
  • Chronic AUB/PALM-COEIN, uterine fibroids
  • IUGR and IUFD 
  • Critically ill gynecologic conditions (TSS, nec fasciitis, septic shock, ARDS)
  • Hematologic disorders in
  • Dysmenorrhea and pelvic pain (including endometriosis, adenomyosis, musculoskeletal pain, IC, fibromyalgia, IBS, pudendal neuralgia)
  • GI disease in pregnancy, including HEG
  • Pelvic organ prolapse 
  • Liver disease in pregnancy
  • Cervical neoplasia 
  • Thyroid disease in pregnancy 
  • Vaginal and vulvar neoplasia  
  • Diabetes in pregnancy 
  • Benign breast conditions and breast cancer 
  • Infectious disease in pregnancy  - maternal
  • Benign vulvar and vaginal disorders 
  • Infectious disease in pregnancy – fetal
  • Acute AUB 
  • Dermatologic disease in pregnancy 
  • Gestational trophoblastic disease  
  • Hypertensive disorders in pregnancy 
  • Mullerian anomalies, ambiguous genitalia   
  • Alloimmunization 
  • Evaluation/management of amenorrhea/galactorrhea


Didactic topics for 2023-2024 (“A” topics)



  • Physiologic changes of pregnancy (immune system changes, CV, pulm, hematologic, renal), pregnancy pharmacokinetics
  •  Physiology of normal menstrual cycle, perimenopause and menopause
  • Antepartum pregnancy counseling (diet, nutritional needs, weight gain, exercise, sexual health, vaccinations)
  •  Anatomy of abdomen and pelvis
  • Postpartum care, including screening and treatment of depression. Breastfeeding, mastitis and breast abscess
  • Preventative and Health Maintenance Care, geriatric care
  • Prenatal genetic screening and diagnosis, carrier screening
  • Trauma-informed care: sexual/physical/elder abuse including IPV
  • Congenital heart disease, cardiopulmonary disease, asthma in pregnancy
  • CV and pulmonary complications of surgery (DVT/PE, MI, stroke, aspiration pneumonia, allergic drug reactions)
  • Neurologic disease in pregnancy
  • Adnexal masses and torsion
  • Renal disease in pregnancy
  • PID and TOA, diverticulitis, appendicitis 
  • Multiple gestation
  • Urinary incontinence
  • Emergent conditions in pregnancy (VTE, AFE, hemorrhage/coagulopathy, eclampsia, CVA)
  • Early pregnancy loss and spontaneous/induced abortion, including mechanism of action of antiprogestins 
  • Cervical insufficiency, short cervix
  • Ovarian and fallopian tube cancer
  • Autoimmune disease in pregnancy
  • Fecal incontinence 
  • Psychiatric disease in pregnancy
  • Infertility
  • Malignancy in pregnancy
  • Cancer genetics


  • Ectopic pregnancy


  • Uterine cancer


  • Benign breast conditions


  • Sexual health and dysfunction


  • Unique concerns for adolescents: Lifestyle choices, relationship, mental health, sexual abuse/assault


  • Pediatric ovarian disease and masses


  • Chemotherapy for gyn cancers

Contact Us